Forte Biosciences

Forecast & Rating5 analysts currently cover Forte Biosciences, with about 20.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $73.80, about 4.0% downside from the current price of $76.89. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 10.3% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Forte Biosciences's outlook. Data as of Aug 13, 2026; for reference only and not investment advice.